Latest News and Blogs

Congenica’s COVID-19 host genetics analysis module, enables researchers to identify genes that influence COVID-19 susceptibility, progression and severity.

We spoke to a number of industry leaders to discuss their thoughts on the culture changes needed to mainstream genomics.

We spoke to a number of industry leaders to find out their thoughts on the importance of improving the efficiency of genetic analysis.

We spoke to a number of industry leaders to discuss their thoughts on the benefits and challenges of mainstreaming genomics and precision medicine

Congenica's response to the UK Government's national genomic healthcare strategy, setting out its vision to extend the UK’s leadership in genomics

Congenica's new module accelerates research into the relationship between an individual’s genomic variation & COVID-19 susceptibility & clinical outcomes.

Using appropriate reference data sources helps to improve diagnostic yield and can support faster interpretation of genomic data.

Is your laboratory being limited in its ability to scale up its interpretation of genetic data due to the genomic analysis bottleneck?

Experts from Congenica provided commentary on a new report from the World Economic Forum, proposing a new way to share genomic data safely and anonymously.

Looking at the impact of cases receiving molecular diagnosis, it is evident that exome sequencing has significant management implications

How laboratories are reducing the interpretation bottleneck by 95% so that laboratories and national programs can solve more cases.

In this release, we made a significant step on our journey to intelligently, safely, and confidently Automate Variant Classification and reporting.